Prostate cancer bone metastases acquire resistance to androgen deprivation via WNT5A-mediated BMP-6 induction

G. T. Lee, D. I. Kang, Y. S. Ha, Y. S. Jung, J. Chung, K. Min, T. H. Kim, K. H. Moon, J. M. Chung, D. H. Lee, W. J. Kim, I. Y. Kim

Research output: Contribution to journalArticlepeer-review

47 Scopus citations

Abstract

Background: Androgen ablation is the first-line therapy for patients with metastatic prostate cancer (CaP). However, castration resistance will eventually emerge. In the present study, we have investigated the role of bone morphogenetic protein-6 (BMP-6) in the development of castration-resistant prostate cancer (CRPC) in the context of bone metastases. Methods: We initially investigated the clinical course of 158 men with advanced CaP who were treated with primary androgen deprivation therapy. To elucidate the underlying mechanism of CRPC in the context of bone metastases, we examined the impact of bone stromal cells on CaP in the absence of androgens using a co-culture model. Results: In the 158 patients, we found that the median time to prostate-specific antigen progression was significantly shorter when bone metastases were present (14 months (95% CI, 10.2-17.8 months) vs 57 months (95% CI, 19.4-94.6 months)). These results suggest that bone-tumour interactions may accelerate castration resistance. Consistent with this hypothesis, in vitro co-cultures demonstrated that CaP cells proliferated under an androgen-depleted condition when incubated with bone stromal cells. Mechanistically, gene expression analysis using quantitative polymerase chain reaction arrays showed a dramatic induction of BMP-6 by CaP cell lines in the presence of bone stromal cells. Further studies revealed that WNT5A derived from bone stromal cells induced the expression of BMP-6 by CaP cells; BMP-6 in turn stimulated cellular proliferation of CaP cells in an androgen-deprived media via a physical interaction between Smad5 and β-catenin. Intracellularly, WNT5A increased BMP-6 expression via protein kinase C/NF-κB pathway in CaP cell lines. Conclusions: These observations suggest that bone-CaP interaction leads to castration resistance via WNT5A/BMP-6 loop.

Original languageEnglish
Pages (from-to)1634-1644
Number of pages11
JournalBritish Journal of Cancer
Volume110
Issue number6
DOIs
StatePublished - 18 Mar 2014

Keywords

  • BMP-6
  • bone metastasis
  • CRPC
  • WNT5A

Fingerprint

Dive into the research topics of 'Prostate cancer bone metastases acquire resistance to androgen deprivation via WNT5A-mediated BMP-6 induction'. Together they form a unique fingerprint.

Cite this